|
 |
 Breakfast Meetings |
Wednesday | April 27 |
Meet the Experts over Breakfast
7:00 AM-8:10 AM |
#1. Bifurcation Intervention:
"Optimizing Stenting Technique"
Organized by CVRF and Supported by Educational Grant from Boston
Scientific Korea
Coronary Arena, Level 1 |
| Moderators: Andrejs Erglis,
William F. Fearon |
| Panelists:
Shaoliang Chen, Hsiao-Yang Cheng, Angela Hoye, Tao Hu, Kiyotaka Iwasaki,
Bon-Kwon Koo, Indulis Kumsars, Song Lin, Jinghua
Liu, Akiko Maehara, Ashok B. Malpani, Issam D. Moussa, Toshiya Muramatsu,
Yoshinobu Murasato, Gaku Nakazawa, Ramdas Nayak, Sreenivas Reddy.S.,
Imad Sheiban, Yoshihisa Shimada, Subban Vijaykumar, Kok Meng Yee |
| 7:00 AM |
Morphology and Distribution
of Atherosclerotic Plaque  |
Gaku Nakazawa |
| 7:10 AM |
Gap Between Anatomy and Function |
William F. Fearon |
| 7:20 AM |
Insights from FFR and IVUS for Bifurcation
PCI ! |
Soo-Jin Kang |
| 7:30 AM |
Is There Any Impact of Intravascular Ultrasound
on Clinical Outcome in Bifurcation Tretament ? |
Imad Sheiban |
| 7:40 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#2. Revascularization
Strategies in Diabetic Patients: "Diabetic Paradox: Is It Real?"
Organized by CVRF and Supported by Educational Grant from Abbott
Vascular
Endovascular Arena, Level 1 |
| Moderators: Takeshi Kimura,
Gregg W. Stone |
| Panelists:
Natsuhiko Ehara, James Flaherty, Kyoo-Rok Han, Vuppaladadhiam Hariram, David Richard Holmes, Soon Jun Hong, Kee-Sik Kim, Spencer B. King III, B. Jayakumar, Seung-Whan Lee, Do-Sun Lim, Rajan Joseph Manjuran, Ichiro Michishita, T R Muralidharan, Seungwoo Park, Taro Saito, Krishnan Suresh, Kin Ming Tam, Nobuhiro Tanaka |
| 7:00 AM |
Comparison of Sirolimus-eluting vs. Everolimus-eluting Stents in Diabetic and Non-Diabetic Patients: Results from the IRIS-DES Registry and the ESSENCE-DIABETES Clinical Trial |
Seung-Whan Lee |
| 7:10 AM |
Differential Treatment Effects of PCI vs. CABG in Diabetic and Non-Diabetic Patients |
David Richard Holmes |
| 7:20 AM |
Is Diabetis Influence Different According
to the Ethnics? Data From J-Cypher Registry |
Takeshi Kimura |
| 7:30 AM |
Optimal Management for Diabetic Patients
with Ischemic Heart disease; Medical, Percutaneous, or Surgical Treatment |
Spencer B. King III |
| 7:40 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#3. Percutaneous Valve
Therapy: "Current and More"
Organized by CVRF
Room 1-1, Level 1 |
| Moderators: Maurice Buchbinder, Ted Feldman, August D. Pichard |
| Panelists:
Paul T.L. Chiam, Jung Rae Cho, Juan Granada, Fumiaki Ikeno, Won-Jang Kim, Michael Kang-Yin Lee, Abdullah Al Shafi Majumder, Sanjeevan Pasupati, Andrew D. Small, Corrado Tamburino |
| 7:00 AM |
Percutaneous Therapy for Mitral Regurgitation |
Ted Feldman |
| 7:10 AM |
Progress Toward a Percutaneously Adjustable Mitral Ring: Micardia |
Maurice Buchbinder |
| 7:20 AM |
Imaging for TAVI Follow-up |
Won-Jang Kim |
| 7:25 AM |
Why Should I Consider Two Different Approaches to tAVR |
August D. Pichard |
| 7:35 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#4. Door to Device - Optimizing Outcomes with Mechanical Support in Cardiogenic Shock
Organized by CVRF and Supported by Educational Grant from Maquet
Medical Korea
Room 2-1, Level 2 |
| Moderator: Tilman Schwab |
| Panelists:
Chul-Min Ahn, Jung-Min Ahn, Jin Ho Choi,
Anand Gnanaraj, Xinming Li, Axel Neitzert, Nanda Kishore
Panigrahi, Parminder Singh, Hongbing Yan, Cheol Woong
Yu |
| 7:00 AM |
Introduction: Guideline Compliance, Utilization,
Trends and Device Selection |
Tilmann Schwab |
| 7:20 AM |
Does the Timing of IABP Matter? |
Jung-Min Ahn |
| 7:40 AM |
Would More Augmentation Be Beneficial? |
Axel Neitzert |
| 8:00 AM |
Take-home Message |
Tilmann Schwab |
| 8:10 AM |
Adjourn |
|
| |
|
|
#5. STEMI Now: Same
Story, Different Tales
Organized by CVRF
Room 3-1, Level 3 |
| Moderators: Stephen G. Ellis,
Mun Kyung Hong |
| Panelists:
Francisco J. Ayala, Jae Woong Choi, Sajid Dhakam, Robbert De Winter, Doni Firman, Hee Hwa Ho, I Chang Hsieh, Myung-Ho Jeong, Narasaraju Kavalipati, Ju Han Kim, Kyung Soo Kim, Yu-Lin Ko, Rohit Khurana, Pramod Kumar Kuchulakanti, Manoj Kumar, Yuk Kong Lau, Cheol Whan Lee, Oteh Maskon, Ajit Mullasari, Yuichi Noguchi |
| |
PCI after Successful Fibrinolysis |
|
| 7:00 AM |
Routine Early |
Mun Kyung Hong |
| 7:10 AM |
Selective Delayed |
Stephen G. Ellis |
| |
Thrombus Aspiration before PCI |
|
| 7:20 AM |
Routine Mandatory |
Robbert De Winter |
| 7:30 AM |
Selective Optional |
Myung-Ho Jeong |
| 7:40 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#6. Evolving Antiplatelet
Therapy: "New Pharmacologic Options for ACS and PCI Patients"
Organized by CVRF
Tutorial Arena, Level 4 |
| Moderators: Roxana Mehran,
Ron Waksman |
| Panelists:
Yunseok Choi, David J. Cohen, Vidhut Kumar Jain, Dong Woon Jeon, Hyo-Soo Kim, Moo Hyun Kim, Nobuyuki Komiyama, Shin Eun Lee, Yohei Ohno, Duk-Woo Park, Jae Hyeong Park, Kyung Woo Park, Kanchanahalli Siddegowda Sadanand |
| 7:00 AM |
Pharmacogenetic Debates in Antiplatelet
Therapy |
Guillaume Pare |
| 7:10 AM |
Optimal Regiment or Duration of Anti-platelet Therapy: Dual vs Triple, 6 vs 12 Months |
Hyo-Soo Kim |
| 7:20 AM |
Relative and Absolute Positive Indication
of Prasugrel and Ticagrelor Beyond Clopidogrel: Clinical Care and
Cost Implications |
David J. Cohen |
| 7:30 AM |
Impact of Bleeding and Tailored or Personalized
Antiplatlet Therapy to Reduce Bleeding in ACS or PCI Patients: From
Clopidogrel to Prasugrel and Ticagrelor |
Roxana Mehran |
| 7:40 AM |
Role of Genotyping and Point-of-Care Testing
in Clopidogrel, Parsugrel, and Ticagrelor |
Ron Waksman |
| 7:50 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
|
Thursday | April 28 |
Meet the Experts over Breakfast
7:00 AM-8:10 AM |
#7.
Left Main Stenting: "Evidence vs. Out of Evidence"
Organized by CVRF and Supported by Educational Grant from Abbott
Vascular
Coronary Arena, Level 1 |
| Moderators: Antonio Colombo,
Corrado Tamburino |
| Panelists:
Mahesh Basarge, Kiyuk Chang, Cheng-I Cheng, Saurab Goel,
Yasumi Igarashi, Percy Parvez Jokhi, Makoto Kadotani,
Po-Ming Ku, Raj Makkar, Fazila Tun-Nesa Malik, Sharma Mridul, Seung-Jung
Park, Afzalur Rahman, G L Sharma, Xuebo Liu, Ping-Han Lo, Yves R.
Louvard, Chetan Shah, Ramesh Singh A/L Arjan Singh, Hiroshi Ueda |
| 7:00 AM |
Angiographic Guidance Is Enough
! |
Yves R. Louvard |
| 7:10 AM |
It's Not Enough ! |
Seung-Jung Park |
| 7:20 AM |
Discussion |
|
| 7:35 AM |
SYNTAX Scoring Before Decision-making ! |
Corrado Tamburino |
| 7:45 AM |
I Do Not Need Any Scoring ! |
Antonio Colombo |
| 7:55 AM |
Discussion |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#8.
Challenging the Complexity of CAD in Asia Pacific
Organized
by CVRF and Supported by Educational Grant from Medtronic Co, Ltd.
Endovascular Arena, Level 1 |
| Moderators: David E. Kandzari,
Michael Kang-Yin Lee |
| 7:00 AM |
Introduction & Objectives |
David E. Kandzari & Michael Kang-Yin Lee |
| 7:03 AM |
Global Perspective of Complex PCI |
David E. Kandzari |
| 7:10 AM |
1st Presenter - (Japan): Present a Complex
PCI of MVD and CTO Patient |
Fuminobu Yoshimachi |
| 7:17 AM |
1st Expert - How We Treat MVD Patient with CTO in Malaysia and Improve Outcomes with These Challenging Procedures |
Amin Ariff Nuruddin |
| 7:24 AM |
Consensus |
|
| 7:29 AM |
2nd Presenter - (Korea): Present a Complex PCI of DM and LM Patient |
June Hong Kim |
| 7:36 AM |
2nd Expert - How We Treat DM Patient with
LM in Korea and Improve Outcomes with These Challenging Procedures |
Bum-Kee Hong |
| 7:43 AM |
Consensus |
|
| 7:48 AM |
3rd Presenter - (HK): Present a Complex
PCI and TAVI Case |
Michael Kang-Yin Lee |
| 7:55 AM |
3rd Expert - How We Treat PCI/TAVI in US
and Improve Outcomes with These Challenging Procedures |
David E. Kandzari |
| 8:02 AM |
Consensus |
|
| 8:07 AM |
Conclusion |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#9.
Pharmacogenomics and Platelet Reactivity Test
Organized by CVRF and Supported Through an Unlimited Educational Grant from Lilly Korea, Ltd. and Daiichi Sankyo Korea Co., Ltd.
Room 1-1, Level 1 |
| Moderators: Duk-Woo Park,
Alan C. Yeung |
| Panelists:
Hwa Wooi Gan, Seung-Ho Hur, Byung Ok Kim,
Moo Hyun Kim, Yoon Seok Koh, Kyung
Woo Park, Yong Whi Park, Ki Bae Seung, Rogelio Ventura Tangco |
| 7:00 AM |
Association of Cytochrome P450 2C19 Polymorphism
with Clinical Efficacy of Clopidogrel in Patients Receiving Elective
PCI |
Ki Bae Seung |
| 7:10 AM |
Association between CYP2C19 Genotype and
Adverse Clinical Outcomes among PCI Patients: A Meta-analysis |
Alan C. Yeung |
| 7:20 AM |
Use of a Point-of-Care Platelet Function
Assay to Improve the Prediction of Atherothrombotic Events after DES
Implantation: ASAN-VerifyNow Registry |
Duk-Woo Park |
| 7:30 AM |
Standard vs. High-Dose Clopidogrel According
to Platelet Function Testing after PCI: Results of the GRAVITAS Trial |
Matthew Price |
| 7:40 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#10.
Innovations in 2011: Now and the Future
Organized
by CVRF
Room 2-1, Level 2 |
| Moderators: Roxana Mehran,
Wan Joo Shim |
| Panelists:
Alaide Chieffo, Yun-Dai Chen, Dong-Ju Choi, So-Yeon Choi, Ted Feldman, Junko Honye, Angela Hoye, Soo-Jin Kang, Akiko Maehara, Piyanart Preeyanont, Krishnan Suresh, Huay Cheem Tan |
| 7:00 AM |
Introductions |
Roxana Mehran |
| 7:05 AM |
The Landscape of Antiplatelet Agents: Which
Drug, for Whom, and Why? |
Matthew Price |
| 7:20 AM |
Update on ACS/AMI: Have We Made Any Progress?
What's Next? |
Huay Cheem Tan |
| 7:35 AM |
Update on Left Main/Multivessel PCI: Lessons
from SYNTAX, a View to EXCEL |
Roxana Mehran |
| 7:45 AM |
Trans-catheter Valve Therapies: Aortic and
Mitral |
Ted Feldman |
| 7:55 AM |
Panel Discussion: How Do Women Fit In? |
Alaide Chieffo & Wan Joo Shim |
| 8:10 AM |
Adjourn |
|
| |
|
|
#11.
How to Treat: Complex Lesions
Organized by CVRF and
Supported by Educational Grant from Terumo Korea Corporation
Room 3-1, Level 3 |
| Moderators: Yuji Hamazaki,
Seung-Woon Rha |
| Panelists:
Bernard Chevalier, Yoon Haeng Cho, Gian Battista Danzi, Hidenari Hozawa, Chi-Hung Huang, Omar Ismail, Chaohui Jiang, Dhiman Kahali, Weon Kim, Masashi Kimura, Menon Bhaskaran Raja Kumar, Ping Liu, Ju-Pin Pan, T. R. Raghu, Shinji Tayama, Taketsugu Tsuchiya, Takashi Yamada, Hiroshi Yamaguchi, Ken Yokoyama, Kan Zen |
| 7:00 AM |
Opening Remarks |
Seung-Woon Rha |
| 7:05 AM |
Nobori in Complex Cases |
Takashi Yamada |
| 7:15 AM |
Round Table Discussion |
|
| 7:25 AM |
How to Overcome Severe Calcified Lesion! |
Yoon Haeng Cho |
| 7:35 AM |
Round Table Discussion |
|
| 7:45 AM |
How Do You Treat This Complex Strange Lesion? |
Weon Kim |
| 7:55 AM |
Round Table Discussion |
|
| 8:05 AM |
Closing Remarks |
Yuji Hamazaki |
| |
|
|
#12.
Vulnerable Plaque: The Challenges Ahead
Organized
by CVRF and Supported by Educational Grant from Volcano(BT+)
Tutorial Arena, Level 4 |
| Moderator: Cheol Whan Lee
|
| Panelists:
Shang-Hung Chang, Marco A. Costa, Guo Sheng Fu, William
Kongto Hau, Young Joon Hong, Lam Kai Huat, Sang Wook Kim, Sung Yun Lee, Chik-Kuan Liao, James R. Margolis, M Pauliina
Margolis, Ron Waksman |
| |
Is There A Vulnerable Plaque? |
|
| 7:00 AM |
[Web-based Lecture] A Believer: Pathologist’s Navigation
Doesn’t Lie! |
Renu Virmani |
| 7:10 AM |
Not a Believer: All Plaques Are Potentially
Vulnerable! |
Ron Waksman |
| |
Looking for Vulnerable Plaque |
|
| 7:20 AM |
New VH Findings: Plaque Stability and Lesion
Risk |
M Pauliina Margolis |
| 7:30 AM |
Plaque Profilings: Insights from the Culprit
Plaques |
Cheol Whan Lee |
| 7:40 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#13.
New DES Technologies
Organized by CVRF
Room 4-1, Level 4 |
| Moderators: Mitchell W. Krucoff,
Barry D. Rutherford |
| Panelists:
Dominic Allocc, Jilin Chen, Rajeev Edakutty, Dong Woon Jeon, Gaku Nakazawa, Yuji Oikawa, Abdullah M.A Shehab |
| 7:00 AM |
Assessment of New Stent Designs: Can We
Balance Ongoing Innovation & Safety Evaluation? |
Mitchell W. Krucoff |
| 7:10 AM |
EPC Capture Stent Program for STEMI |
Harry Suryapranata |
| 7:20 AM |
Traditional and Novel Metal Alloys: Advantages,
Disadvantages and Trends |
Juan Granada |
| 7:30 AM |
Can Biodegradable Polymer DES Be Better than 2nd Generation DES? |
Gaku Nakazawa |
| 7:40 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#14.
Drug-coated Stent or Balloon for PVD "New Horizon for PVD"
Organized by CVRF
Room 4-2, Level 4 |
| Moderators: John R. Laird,
Jr., Andrej Schmidt |
| Panelists:
Taehoon Ahn, Motoharu Araki, Mark W. Burket, Gim Hooi Choo, Debabrata
Dash, Richard R. Heuser, Chung-Ho Hsu, Naoto Inoue, Upendra Kaul,
Issam D. Moussa, Sreenivas Reddy.S., Manish Taneja |
| 7:00 AM |
The Promise of Tibial Drug-Coated Balloons |
Andrej Schmidt |
| 7:12 AM |
Will Drug-coated Balloons, Drug-coated Stents
Shift the Paradigm for Femoropopliteal Lesion |
Mark W. Burket |
| 7:24 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
|
Friday | April 29 |
Meet the Experts over Breakfast
7:00 AM-8:10 AM |
#15. Paradigm Shift
to "Functional Angioplasty"
Organized by CVRF and Supported by Educational Grant from St.
Jude Medical
Coronary Arena, Level 1 |
| Moderators: William Fearon,
John McB. Hodgson |
| Panelists:
Masaki Awata, Wacin Buddhari, Feng Cao, Yoon Haeng Cho, Cheol Ung Choi, Yoon Sin Chong, David J. Cohen, Soo-Jin Kang, Bon-Kwon Koo, Indulis Kumsars, Jin Bae Lee, Chang-Wook Nam, Kin Ming Tam, Ping Tim Tsui, Ki Dong Yoo |
| 7:00 AM |
Cost-effectiveness of PCI vs.
CABG in Multivessel CAD: Implication of an FFR-guided Strategy? |
David J. Cohen |
| 7:10 AM |
How and Why to Assess the Coronary Microvasculature |
William Fearon |
| 7:20 AM |
Appropriateness in Imaging: Why We Need
to Pay Attention |
John McB. Hodgson |
| 7:30 AM |
IVUS-FFR: Optimal Cut-off of MLA |
Soo-Jin Kang |
| 7:40 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#16. Carotid Stenting
"Best Licence for Carotid Revascularization"
Organized by CVRF and Supported by Educational Grant from Abbott
Vascular
Endovascular Arena, Level 1 |
| Moderators: Paul Hsien-Li Kao, John R. Laird, Jr |
| Panelists:
Paul T. L. Chiam, Si Wan Choi, Dae Hyun Hwang, Jae-Hwan Lee, Mao-Shin Lin, Horst Sievert |
| 7:00 AM |
Normal Risk Symptomatic Patients, On-going
Debate; CAS vs CEA? |
John R. Laird, Jr |
| 7:10 AM |
Is Protection Device of Benefit or Not ? |
Paul Hsien-Li Kao |
| 7:20 AM |
Asymptomatic Carotid Stenosis: Optimal Medical
Treatment vs. Revascularization |
Jae-Hwan Lee |
| 7:30 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#17. Revascularization
for Multivessel Coronary Disease
"Complete Revascularization: The Link Between Anatomy and Function"
Organized by CVRF
Room 1-1, Level 1 |
| Moderators: Mun Kyung Hong, Imad Sheiban |
| Panelists:
Amal Kumar Banerjee, Jayesh Bhaskaran, Dong Bin Kim, Young-Hak Kim, Ng Kok Huan, Michael S. Lee, Yves R. Louvard, Naoki Masuda, Atsunori Okamura, Narendar Tanwar |
| 7:00 AM |
Does High SYNTAX Score Always Means Bypass
Surgery in Multivessel Disease Patients ? |
Imad Sheiban |
| 7:10 AM |
What We Will Learn from FREEDOM and ISCHEMIA Trials ? |
Mun Kyung Hong |
| 7:20 AM |
Impact of Complete Revascularization Strategy |
Young-Hak Kim |
| 7:30 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#18.
OCT- "The 2nd Generation OCT Is Useful to Assess Complex Coronary
Lesions"
Organized by CVRF and Supported by Educational Grant from St.
Jude Medical
Room 2-1, Level 2 |
| Moderators: Takashi Akasaka,
Gary S. Mintz |
| Panelists:
So-Yeon Choi, Kenichi Fujii, Jung-Ho Heo, Myeong-Ki Hong, Junko Honye, Sang Wook Kim, Takashi Kubo, Setsuo Kumazaki, Akiko Maehara, Yukio Ozaki, Junya Shite, Atsushi Takagi, Alan C. Yeung |
| 7:00 AM |
Advantage of 2nd Generation OCT; OCT
Is Useful to Assess Complex Coronary Lesions |
Gary S. Mintz |
| 7:10 AM |
Is OCT Helpful for CTO Intervention? |
Akiko Maehara |
| 7:20 AM |
2nd Generation OCT: Recent Advances and
Future Direction |
Wang-Yuhl Oh |
| 7:30 AM |
Experiences of 2nd Generation OCT in Assessment
of Complex Coronary Lesions; Can It Give Us Additive Useful Information? |
Alan C. Yeung |
| 7:40 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#19. Techniques for
CTO Intervention "Best Selection and Right Direction"
Organized by CVRF
Room 3-1, Level 3 |
| Moderators: Etsuo Tsuchikane,
Seung-Woon Rha |
| Panelists:
Yuzo Akita, Paiboon Chotnoparatpat, Anand Gnanaraj, Ryo
Gotoh, Yuji Ikari, Naoto Inoue, Yoshihiro Kato, Idris Ahmed Khan,
Jacques J. Koolen, Feng Yu Kuo, Nae Hee Lee, Linda Lison, Genshan
Ma, Motomaru Masutani, Satoru Otsuji, Sang-Ho Park, Chun-Hung Su,
Jon Suh, Satoru Sumitsuji, Kenji Wagatsuma, Chiung-Jen Wu, Bin Zhang |
| |
Featured Lectures |
|
| 7:00 AM |
Antegrade Journey with Expanded New Device
? |
Etsuo Tsuchikane |
| 7:10 AM |
Retrograde Approach: When and How ? |
Nae Hee Lee |
| |
Case Presentations |
|
| 7:20 AM |
Invited Case Presentation & Focus Review:
CTO- The European Approach |
Jacques J. Koolen |
| 7:30 AM |
Invited Case Presentation & Focus Review:
Contemprorary CTO |
Satoru Sumitsuji |
| 7:40 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
| |
|
|
#20. Role of Noninvasive
CT Imaging in Daily Practice: A Case-Based Approach
Organized by CVRF
Tutorial Arena, Level 4 |
| Moderators: Yeon Hyeon Choe, Wm. Guy Weigold |
| Panelists:
Koichiro Asawa, Hsiao-Yang Cheng, Byong Wook Choi, Yu Jeong Choi, Purvez Grant, Joon-Won Kang, Won-Jang Kim, Sung Uk Kwon, James K. Min, Hidetaka Nishina, Taro Saito, Kou-Gi Shyu, Tao-Cheng Wu |
| 7:00 AM |
Clinical Assessment of Paitent-specific
Risk |
Wm. Guy Weigold |
| 7:10 AM |
Non-coronary, Non-cardiac Findings on CT
|
Joon-Woon Kang |
| 7:20 AM |
Therapeutic Benefit of Revascularization
Based upon Non-invasive Cardiac Imaging |
James K. Min |
| 7:30 AM |
Panel Discussion and Q & A |
|
| 8:10 AM |
Adjourn |
|
|
|
|
|
